• 약학회지
• /
• 제47권6호
• /
• pp.404-409
• /
• 2003

To investigate the effect of chitosan oligosaccharide on melanin synthesis, we measured tyrosinase activity and melanin production in B16 melanoma cells. Chitosan oligosacchaide itself did not have any anti-oxidant activity in DPPH radical scavenging, and did not affect the proliferation of B16 melanoma cells. Chitosan oligosaccharide dose-dependently increased melanin production in the absence or presence of MSH. However, chitosan oligosaccharide did not have any influence on the tyrosinase activity and tyrosinase expression in B16 melanoma cells. These results suggest that chitosan oligosaccharide-induced melanin production may be independent on tyrosinase activity in B16 melanoma cells. From the above results. chitosan oligosaccharide dose-dependently appears to increase melanin production in B16 melanoma cells, suggesting that chitosan oligosaccharide may be used as a tanning agent.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제7권5호
• /
• pp.263-267
• /
• 2002

Our purpose is to develop an efficient synthetic method of obtaining oligosaccharide unit in sufficient amounts to study functions of glycans. Many exoglycosidases have been used as tools for the oligosaccharide synthesis. In contrast, a limited number of reports are available on the utilization of endoglycosidases. We describe herewith the efficient synthetic method of useful oligosaccharides and derivatives as biomaterials utilizing lysozyme, cellulase, and lacto-N-biosidase-mediated transglycosyltions.

• 대한방사선기술학회지:방사선기술과학
• /
• 제33권4호
• /
• pp.321-326
• /
• 2010

본 연구에서는 미역이나 다시마에 많이 분포하면서 항산화작용이 탁월한 알긴산올리고당의 방사선 방어효과를 알아보기 위해 3 Gy 방사선이 전신 1회 조사된 마우스를 가지고 IL-6을 측정하였다. 측정 결과 방사선조사대조군과 비교하여 볼 때 소장과 간 조직 모두 방사선조사 전 7일간 알긴산올리고당의 처치를 시행한 그룹에서 IL-6 생성이 억제됨을 관찰하였다(p < 0.001). 이는 알긴산올리고당이 항산화작용을 통해 방사선이 피폭된 생체조직을 방어함으로써 IL-6의 생성을 억제한 것으로 사료된다. 결론적으로, 본 연구를 통해 알긴산올리고당의 일부 방사선 방어효과를 규명했고 아울러 화학적 독성이 없는 자연산생물이 방사선 방어제로 활용될 수 있을 가능성을 확인하였다.

• 한국섬유공학회:학술대회논문집
• /
• 한국섬유공학회 1997년도 추계총회 및 학술발표회 논문집
• /
• pp.81-85
• /
• 1997

• KSBB Journal
• /
• 제23권6호
• /
• pp.474-478
• /
• 2008

효율적인 UDP-glucose regeneration system을 구축하기 위해서 재순환 시스템에 관여하는 4가지 효소 (UDP-glucose pyrophosphorylase, UDP-Kinase gene, UDP-galactose 4-epimerase, and $\beta$-1, 4-galactasyltrasnsferase)들을 E. coli AD202에서 발현 시켜 Disaccharide 합성 정도를 보았다. Disaccharide는 0.5 mM IPTG 농도에서 가장 높은 농도를 나타내었다. 대조구와 비교한 결과 LacNAc 농도는 1.34 mM로 10배 정도 정가하였고, lactose 농도는 0.39 mM로 대조구보다 2.6배 증가하였다. 총 disaccharide 농도는 1.73 mM 이며, 대조구 보다 6.5배 높은 생산성을 보였다. 본 논문은 결과는 metabolic flux regeneration으로 disaccharides 합성을 증가시킬 수 있다는 것을 보여주었다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
• /
• pp.89-90
• /
• 2002

• Macromolecular Research
• /
• 제11권2호
• /
• pp.115-121
• /
• 2003

In this research, the in vitro anti-thrombogenecity of artificial materials was evaluated using hydrophilic/hydrophobic copolymers containing oiligosaccharide as hydrophilic moiety and phospholipid as hydrophobic moiety respectively. N-(p-vinylbenzyl)-[O-$\alpha$-D-glucopyranosyl-(1longrightarrow4)]$_{n-1}$-D-glucoamide(VM7A) was (VM7 A) was adopted as hydrophilic oligosaccharide and 2-acryloxybutyl-2-(triethylammonium)ethyl phosphoric acid (HBA-choline) was adopted as hydrophobic phospholipid. Copolymers having various monomer feeding molar ratios were synthesized through radical polymerization. The synthesized copolymers were identified using FT-IR, $^1$H-NMR, XPS, and DSC. The surface energy of the copolymers were evaluated by dynamic contact angle (DCA) method and checked different roles of VM7A as hydrophilic moiety and HBA-choline as hydrophobic moiety on surface. The surface morphological differences between hydrated and unhydrated surfaces of copolymers were observed and evaluated using Am. The platelets were separated from canine whole blood by centrifugation and adopted to the anti-thromobogenecity test of the copolymers. From the results, we find out that as VM7A ratio increases, so did anti-thrombogenecity. Such results show the possibility of using these copolymers as blood compatible materials in living body.y.

• 산업식품공학
• /
• 제21권4호
• /
• pp.383-390
• /
• 2017

국내 재래시장에서 수집한 발효식품 등에서 우수한 glucansucrase 활성을 나타내는 유산균주를 분리한 후 이 균주를 이용한 올리고당 생성의 최적 조건을 조사하였다. 배추김치로부터 분리된 유산균주 CCK940은 glucansucrase 활성이 918.2 mU/mL로 가장 높아 본 올리고당 생산을 위한 균주로 선정하였고, Leu. lactis CCK940로 동정 및 명명되었다. 선정된 Leu. lactis CCK940는 배지의 pH를 6.0으로 조정하고 공여체인 sucrose와 수용체인 maltose의 초기 농도를 각각 5% (w/v)와 10% (w/v)로 첨가한 후 배양 4시간과 8시간째에 sucrose를 5% (w/v) 첨가하는 것이 최적인 것으로 확인되었다. 최적 조건에 12시간 배양 시 Leu. lactis CCK940는 중합도가 2-4인 올리고당을 최소 4종류 생성하였다. 본 균주는 수용체 분자로서 fructose와 melibiose를 사용할 수 없었다.

• Food Science and Biotechnology
• /
• 제17권3호
• /
• pp.514-518
• /
• 2008

After overproduction of a recombinant $\beta$-galactosidase of Bifidobacterium infantis in Pichia pastoris, a synthesis of galacto-oligosaccharides (GOS) from 36% lactose using the enzyme (170.74 U/mg) was investigated. The transgalactosylation ratio reached up to 25.2% with 83.1% conversion of initial lactose and the maximum yield of GOS was 40.6%. The GOS syrup was composed of a 13.43% galacto-oligosaccharides, 5.06% lactose, and 8.76% monosaccharides. The prebiotic effect of GOS on the growth of bifidobacteria and lactobacilli strains was investigated in vitro. The maximum growth rate of Bifidobacterium breve and Lactobacillus acidophillus in GOS syrup (5%, v/v) media were 0.49 and 0.96/hr that are higher than those in 1%(w/v) galactose and 1%(w/v) lactose containing media. However, there was no significant difference between the specific growth rates of L. acidophillus in 1%(w/v) glucose and 5%(v/v) GOS syrup. Our data showed that GOS definitely promoted the growth of B. breve ATCC $15700^T$ and L. acidophilus ATCC 33323.

• Journal of Microbiology and Biotechnology
• /
• 제18권5호
• /
• pp.859-865
• /
• 2008

Bacterial glycosyltransferases have drawn growing attention as economical enzymes for oligosaccharide synthesis, with their easy expression and relatively broad substrate specificity. Here, we characterized a glycosyltransferase homolog (Fnu_GT) from a human oral pathogen, Fusobacterium nucleatum. Bioinformatic analysis showed that Fnu_GT belongs to the glycosyltransferases family II. The recombinant Fnu_GT (rFnu_GT) expressed in Escherichia coli displayed the highest glycosylation activity when UDP-galactose (Gal) was used as a donor nucleotide-sugar with heptose or N-acetylglucosamine (GlcNAc) as an acceptor sugar. Interestingly, rFnu_GT transferred the galactose moiety of UDP-Gal to a nonreducing terminal GlcNAc attached to the trimannosyl core glycan, indicating its potential as an enzyme for human-type N-glycan synthesis.